Philogen SpA

Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue Sarcoma

20 2 2024 00:30:00 提供 Nasdaq GlobeNewswire

Philogen S.p.A. announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by Competent Authorities

05 12 2023 01:30:00 提供 Nasdaq GlobeNewswire

Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors

04 12 2023 02:00:00 提供 Nasdaq GlobeNewswire

Nidlegy™ Phase III PIVOTAL trial meets the study’s primary objective demonstrating statistically significant and clinically meaningful improvement in Recurrence-Free Survival for patients with locally advanced fully resectable melanoma

16 10 2023 07:21:36 提供 Nasdaq GlobeNewswire

Philogen Announces Clinical Trial Collaboration with MSD

01 6 2023 01:30:00 提供 Nasdaq GlobeNewswire

Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand

30 5 2023 00:00:00 提供 Nasdaq GlobeNewswire

Philogen Publishes New Data on a Fibromun-based treatment combination in Science Translational Medicine in collaboration with the University Hospital Zürich

25 5 2023 01:00:00 提供 Nasdaq GlobeNewswire

Philogen Announces Publication of a New Study in Collaboration with Google focused on Machine Learning models applied to DNA-Encoded Chemical Library Technology

28 3 2023 01:00:00 提供 Nasdaq GlobeNewswire

Philogen Provides Corporate Update

01 12 2022 01:00:00 提供 Nasdaq GlobeNewswire

Philogen Provides Corporate Update

23 6 2022 02:00:00 提供 Nasdaq GlobeNewswire

Philochem and Bracco Imaging Announce a Collaboration on the Development of a Small Molecule for Diagnostic or Medical Imaging Applications

22 3 2022 02:05:00 提供 Nasdaq GlobeNewswire

Philogen announces publication of PET clinical data with proprietary ultra-high affinity FAP-targeting small molecule ligand (OncoFAP)

07 1 2022 01:00:00 提供 Nasdaq GlobeNewswire

PHILOGEN ANNOUNCES NEW COLLABORATION WITH JANSSEN TO DISCOVER SMALL MOLECULE THERAPEUTICS

24 11 2021 02:00:00 提供 Nasdaq GlobeNewswire

Philogen Provides Corporate Update

12 11 2021 01:00:00 提供 Nasdaq GlobeNewswire

Philogen Provides Corporate Update

29 9 2021 03:58:35 提供 Nasdaq GlobeNewswire

Philogen Announces R&D Program Update

02 7 2021 01:00:00 提供 Nasdaq GlobeNewswire

Philogen Announces First Quarter 2021 Results and Provides Update on Pipeline Progress

12 5 2021 12:00:00 提供 Nasdaq GlobeNewswire